| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 1,250 | $1.35 | $1,682.20 | +0.7% | -31.5% | - | |
| Sep 11, 2025 | ATR Aptargroup, Inc. | Touya Gael59 | Segment President | Sell | 2,500 | $136.12 | $340,297.79 | -3.8% | -14.5% | - | |
| Sep 11, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 630 | $26.83 | $16,902.90 | -0.2% | -7.4% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Boniface John J.56 | Chief Scientific Officer | Sell | 1,395 | $3.13 | $4,366.35 | -0.9% | +10.7% | - | |
| Sep 11, 2025 | BLFS Biolife Solutions Inc | Werner Sean64 | Chief Technology Officer | Sell | 72 | $26.83 | $1,931.76 | -0.3% | -7.4% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Kearney Paul81 | Chief Data Officer | Sell | 1,271 | $3.13 | $3,978.23 | -0.7% | +10.7% | - | |
| Sep 11, 2025 | GKOS Glaukos Corp | Navratil Tomas59 | Chief Development Officer | Sell | 5,142 | $88.22 | $453,620.40 | -3.3% | +24.3% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin82 | Chief Financial Officer | Sell | 915 | $3.13 | $2,863.95 | -0.3% | +10.7% | - | |
| Sep 11, 2025 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 41,040 | $27.53 | $1,129,831.20 | -55.5% | +7.3% | - | |
| Sep 11, 2025 | ELMD Electromed, Inc. | Summers Andrew79 | Director | Sell | 65,714 | $24.32 | $1,598,453.61 | -60.3% | +16.3% | - | |
| Sep 10, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 1,500 | $1.34 | $2,010.00 | +1.3% | -30.7% | - | |
| Sep 10, 2025 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 192,599 | $14.48 | $2,788,624.34 | +0.1% | -7.3% | - | |
| Sep 10, 2025 | BDX Becton Dickinson & Co | Fraser Claire55 | Director | Sell | 917 | $187.50 | $171,937.50 | -4.0% | +0.8% | - | |
| Sep 10, 2025 | RGEN Repligen Corp | Hunt Anthony75 | Director | Sell | 29,111 | $120.52 | $3,508,388.91 | -4.0% | +33.6% | - | |
| Sep 10, 2025 | AZTA Azenta, Inc. | Marotta John | President And CEO | Sell | 316 | $29.41 | $9,293.56 | -0.3% | +21.6% | - | |
| Sep 9, 2025 | ATEC Alphatec Holdings, Inc. | Berkowitz Mortimer III | Director | Sell | 62,500 | $15.97 | $998,125.00 | -9.2% | +32.7% | - | |
| Sep 9, 2025 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner76 | Chief Information Officer | Sell | 2,000 | $3.05 | $6,100.00 | -1.9% | -1.6% | - | |
| Sep 9, 2025 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya81 | Chief Executive Officer | Sell | 21,158 | $3.15 | $66,647.70 | -2.5% | -1.6% | - | |
| Sep 9, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 1,500 | $1.37 | $2,055.00 | +2.7% | -32.0% | - | |
| Sep 9, 2025 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.54 | Director, 10% Owner | Buy | 100,000 | $1.29 | $128,920.00 | +0.2% | +14.1% | - | |
| Sep 9, 2025 | SERA Sera Prognostics, Inc. | Lawrence Sandra Aj56 | Director | Sell | 3,899 | $3.05 | $11,891.95 | -17.2% | -1.6% | - | |
| Sep 9, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin82 | Chief Financial Officer | Sell | 5,263 | $3.15 | $16,578.45 | -1.8% | -1.6% | - | |
| Sep 8, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 500 | $1.40 | $700.00 | +0.9% | -33.0% | - | |
| Sep 8, 2025 | ZBH Zimmer Biomet Holdings, Inc. | Winkler Lori66 | SVP And CHRO | Sell | 1,500 | $104.15 | $156,225.00 | -18.0% | -11.4% | - | |
| Sep 8, 2025 | WRBY Warby Parker Inc. | Cutler Joel E89 | - | Sell | 35,000 | $26.75 | $936,351.50 | -63.7% | -20.5% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.